Rapid Micro Biosystems (RPID) Cash from Financing Activities (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Cash from Financing Activities of $247000.0 for Q1 2026, down 44.24% sequentially from $443000.0 in Q4 2025, and down 34.83% YoY from $379000.0 in Q1 2025.
Rapid Micro Biosystems (RPID) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Cash from Financing Activities for 7 years, with the latest figure at $247000.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 34.83% year-over-year to $247000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (up 4531.84% YoY) and the FY2025 annual result came in at $19.8 million, up 9639.41% from the prior year.
- Cash from Financing Activities declined to $247000.0 in Q1 2026 per RPID's latest filing, from $443000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $19.2 million in Q3 2025 and troughed at -$298000.0 in Q2 2025.
- A 5-year average of $1.2 million and a median of $87000.0 in 2022 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 31452.46% in 2025, down 2880.0% in 2025.
- Over 5 years, Cash from Financing Activities stood at $87000.0 in 2022, then slumped by 113.79% to -$12000.0 in 2023, then jumped by 50.0% to -$6000.0 in 2024, then surged by 7483.33% to $443000.0 in 2025, then slumped by 44.24% to $247000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $247000.0, $443000.0, and $19.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Rapid Micro Biosystems | 80.26 Mn | 60.49 Mn | 1.21 Mn | 9.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.35 Mn |
| Jun 30, 2026 | 9.35 Mn |
| Mar 31, 2026 | 247,000.00 |
| Mar 31, 2026 | 247,000.00 |
| Dec 31, 2025 | 443,000.00 |
| Dec 31, 2025 | 443,000.00 |
| Sep 30, 2025 | 19.25 Mn |
| Sep 30, 2025 | 19.25 Mn |
| Jun 30, 2025 | -298,000.00 |
| Jun 30, 2025 | -298,000.00 |
| Mar 31, 2025 | 379,000.00 |
| Mar 31, 2025 | 379,000.00 |
| Dec 31, 2024 | -6,000.00 |
| Dec 31, 2024 | -6,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | 158,000.00 |
| Mar 31, 2024 | 158,000.00 |